Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Investing Activities: 2023-2025

Historic Cash from Investing Activities for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $36,000.

  • Camp4 Therapeutics' Cash from Investing Activities was N/A to $36,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$669,000, marking a year-over-year change of. This contributed to the annual value of -$441,000 for FY2024, which is 34.96% up from last year.
  • Camp4 Therapeutics' Cash from Investing Activities amounted to $36,000 in Q3 2025, which was up 112.90% from -$279,000 recorded in Q1 2025.
  • Camp4 Therapeutics' 5-year Cash from Investing Activities high stood at $36,000 for Q3 2025, and its period low was -$279,000 during Q1 2025.
  • In the last 3 years, Camp4 Therapeutics' Cash from Investing Activities had a median value of -$203,000 in 2023 and averaged -$154,500.
  • Data for Camp4 Therapeutics' Cash from Investing Activities shows a maximum YoY slumped of 1,760.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Cash from Investing Activities stood at -$243,000 in 2023, then fell by 8.23% to -$263,000 in 2024, then crashed by 1,760.00% to $36,000 in 2025.
  • Its Cash from Investing Activities was $36,000 in Q3 2025, compared to -$279,000 in Q1 2025 and -$263,000 in Q4 2024.